Eva Åkerblom

1.5k citations

49 papers · 1.3k indexed · h-index 19

Impact in

Hepatology top 5%
- Hepatitis C virus research
Pharmaceutical Science top 5%

Papers in ⓘ

Hepatology 19
- Hepatitis C virus research 19
Infectious Diseases 14
- HIV/AIDS drug development and treatment 14

Co-authors: Ary Wolfgang Richter (2 shared papers)U. Helena Danielson (19 shared papers)Anja Sandström (15 shared papers)Anja Johansson (6 shared papers)Anders Hallberg (6 shared papers)Gunnar Lindeberg (8 shared papers)Terje Kalland (4 shared papers)Mikael Dohlsten (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry (10 papers)Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry (7 papers)International Archives of Allergy and Immunology (4 papers)Journal of Medicinal Chemistry (4 papers)Molecular Diversity (2 papers)
Partner nations: Sweden Belgium

In The Last Decade

Eva Åkerblom

49 papers receiving 1.2k citations

Peers

Countries citing papers authored by Eva Åkerblom

Since Specialization

Citations

This map shows the geographic impact of Eva Åkerblom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Åkerblom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Åkerblom more than expected).

Fields of papers citing papers by Eva Åkerblom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Åkerblom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Åkerblom. The network helps show where Eva Åkerblom may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Åkerblom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Åkerblom Line = papers co-authored together Eva Åkerblom links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Antibodies against Polyethylene Glycol Produced in Animals by Immunization with Monomethoxy Polyethylene Glycol Modified Proteins International Archives of Allergy and Immunology ·Ary Wolfgang Richter, Eva Åkerblom	1983	232
2	Polyethylene Glycol Reactive Antibodies in Man: Titer Distribution in Allergic Patients Treated with Monomethoxy Polyethylene Glycol Modified Allergens or Placebo, and in Healthy Blood Donors International Archives of Allergy and Immunology ·Ary Wolfgang Richter, Eva Åkerblom	1984	189
3	Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proceedings of the National Academy of Sciences ·Mikael Dohlsten, Gunnar Hedlund, Eva Åkerblom, Peter A. Lando, Terje Kalland	1991	90
4	Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase): A comparative study of different C-terminals Bioorganic & Medicinal Chemistry ·Anja Johansson, Anton Poliakov, Eva Åkerblom, Karin Wiklund, Gunnar Lindeberg, Susanne Winiwarter, U. Helena Danielson, Bertil Samuelsson, Anders Hallberg	2003	85
5	Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitors Bioorganic & Medicinal Chemistry ·Robert Rönn, Thomas Gossas, Yogesh Sabnis, Hanna Daoud, Eva Åkerblom, U. Helena Danielson, Anja Sandström	2007	45
6	Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3 Bioorganic & Medicinal Chemistry ·Robert Rönn, Yogesh Sabnis, Thomas Gossas, Eva Åkerblom, U. Helena Danielson, Anders Hallberg, Anja Johansson	2005	44
7	Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors Bioorganic & Medicinal Chemistry ·Pernilla Örtqvist, Shane D. Peterson, Eva Åkerblom, Thomas Gossas, Yogesh Sabnis, Rebecca Fransson, Gunnar Lindeberg, U. Helena Danielson, Anders Karlén, Anja Sandström	2006	41
8	Tetrapeptides as potent protease inhibitors of hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase) Bioorganic & Medicinal Chemistry ·Anja Johansson, Anton Poliakov, Eva Åkerblom, Gunnar Lindeberg, Susanne Winiwarter, Bertil Samuelsson, U. Helena Danielson, Anders Hallberg	2002	36
9	Synthesis and structure-activity relations of a series of antibacterially active 5-(5-nitro-2-furfurylidene)thiazolones, 5-(5-nitro-2-furylpropenylidene)thiazolones, and 6-(5-nitro-2-furyl)-4H-1,3-thiazinones Journal of Medicinal Chemistry ·Eva Åkerblom	1974	31
10	An Improved Procedure for N- to C-Directed (Inverse) Solid-Phase Peptide Synthesis Journal of Combinatorial Chemistry ·Anja Johansson, Eva Åkerblom, Karolina Ersmark, Gunnar Lindeberg, Anders Hallberg	2000	29
11	Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain Bioorganic & Medicinal Chemistry Letters ·Anja Johansson, Ina Hubatsch, Eva Åkerblom, Gunnar Lindeberg, Susanne Winiwarter, U. Helena Danielson, Anders Hallberg	2001	27
12	Suppression of reaginic antibodies with modified allergens. IV. Induction of suppressor T cells by conjugates of polyethylene glycol (PEG) and monomethoxy PEG with ovalbumin. PubMed ·W Y Lee, A.H. Sehon, Eva Åkerblom	1981	26
13	Suppression of reaginic antibodies with modified allergens. III. Preparation of tolerogenic conjugates of common allergens with monomethoxypolyethylene glycols of different molecular weights by the mixed anhydride method. PubMed ·Wie Si, Wie Cw, W Y Lee, Filion Lg, Sehon Ah, Eva Åkerblom	1981	24
14	B-Domain Deleted Recombinant Coagulation Factor VIII Modified with Monomethoxy Polyethylene Glycol Bioconjugate Chemistry ·Johanna Röstin, Anna‐Lisa Smeds, Eva Åkerblom	2000	23
15	Effects on protease inhibition by modifying of helicase residues in hepatitis C virus nonstructural protein 3 FEBS Journal ·Göran Dahl, Anja Sandström, Eva Åkerblom, U. Helena Danielson	2007	22
16	Induction of Basophilic Differentiation in the Human Basophilic Cell Line KU812 Scandinavian Journal of Immunology ·Ingrid Almlöf, Kenneth Nilsson, Viktoria Johansson, Eva Åkerblom, H. SLOTTE, S. Ahlstedt, P. Matsson	1988	21
17	Resistance Profiling of Hepatitis C Virus Protease Inhibitors using Full-Length NS3 Antiviral Therapy ·Göran Dahl, Anja Sandström, Eva Åkerblom, U. Helena Danielson	2007	20
18	Achiral Pyrazinone-Based Inhibitors of the Hepatitis C Virus NS3 Protease and Drug-Resistant Variants with Elongated Substituents Directed Toward the S2 Pocket Journal of Medicinal Chemistry ·Johan Gising, Anna Karin Belfrage, Hiba Alogheli, Angelica E. Ehrenberg, Eva Åkerblom, Richard Svensson, Per Artursson, Anders Karlén, U. Helena Danielson, Mats Larhed, Anja Sandström	2013	19
19	Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Bioorganic & Medicinal Chemistry ·Robert Rönn, Anna Lampa, Shane D. Peterson, Thomas Gossas, Eva Åkerblom, U. Helena Danielson, Anders Karlén, Anja Sandström	2008	18
20	Structure–activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors Biochimica et Biophysica Acta (BBA) - General Subjects ·Anton Poliakov, Anja Johansson, Eva Åkerblom, Karin Oscarsson, Bertil Samuelsson, Anders Hallberg, U. Helena Danielson	2004	16

About Eva Åkerblom

Eva Åkerblom is a scholar working on Hepatology, Infectious Diseases, Immunology and Allergy, Organic Chemistry and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (19 papers), HIV/AIDS drug development and treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers), Synthesis and biological activity (6 papers), Click Chemistry and Applications (6 papers), Chemical Synthesis and Analysis (5 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Hepatology (255 citations), Pharmaceutical Science (82 citations), Biomaterials (164 citations), Radiology, Nuclear Medicine and Imaging (274 citations) and Organic Chemistry (309 citations). Eva Åkerblom has collaborated with scholars based in Sweden and Belgium. Frequent co-authors include Ary Wolfgang Richter, U. Helena Danielson, Anja Sandström, Anja Johansson, Anders Hallberg, Gunnar Lindeberg, Terje Kalland, Mikael Dohlsten, Peter A. Lando and Thomas Gossas. Their work appears in journals such as Bioorganic & Medicinal Chemistry, Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry, International Archives of Allergy and Immunology, Journal of Medicinal Chemistry and Molecular Diversity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact